Hexagon Capital Partners LLC Laboratory Corp Of America Holdings Transaction History

Hexagon Capital Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$197.69 - $227.29 $2,767 - $3,182	-14 Reduced 4.68%	285 $64,000
Q3 2023 Oct 23, 2023	SELL	$201.05 - $221.7 $603 - $665	-3 Reduced 0.99%	299 $60,000
Q2 2023 Jul 24, 2023	SELL	$211.93 - $241.33 $1,271 - $1,447	-6 Reduced 1.95%	302 $72,000
Q1 2023 Apr 24, 2023	SELL	$213.32 - $257.83 $7,039 - $8,508	-33 Reduced 9.68%	308 $70,000
Q4 2022 Jan 13, 2023	SELL	$203.72 - $248.97 $5,500 - $6,722	-27 Reduced 7.34%	341 $0
Q3 2022 Oct 17, 2022	BUY	$204.81 - $262.19 $1,024 - $1,310	5 Added 1.38%	368 $75,000
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $549 - $616	-2 Reduced 0.55%	363 $102,000
Q2 2021 Aug 11, 2021	BUY	$251.87 - $278.14 $3,274 - $3,615	13 Added 3.69%	365 $101,000
Q1 2021 May 13, 2021	SELL	$204.88 - $255.03 $204 - $255	-1 Reduced 0.28%	352 $89,000
Q3 2020 Nov 10, 2020	BUY	$167.03 - $201.3 $58,961 - $71,058	353 New	353 $73,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.